[Effect of Recombinant Adenovirus AdE-SH2-Caspase 8 on the Apoptosis of Imatinib-resistant K562/G01 Cell Line]

Lin Wang1,2, Chang Fei1, Zheng-Lan Huang2

  • 1College of Laboratorial Medicine, Hunan University of Medicine, Huaihua 418000, Hunan Province, China.

Abstract

Insights

Recombinant adenovirus expressing SH2-Caspase 8 fusion protein effectively induces apoptosis in imatinib-resistant K562/G01 chronic myeloid leukemia cells, increasing Caspase 3 and PARP expression.

Area of Science:

  • Molecular biology
  • Cancer research
  • Virology

Context:

  • K562/G01 cells are a BCR/ABL positive chronic myeloid leukemia cell line resistant to imatinib.
  • Recombinant adenovirus AdE-SH2-Caspase8-HA-GFP (SC) was used to deliver the SH2-Caspase 8 fusion protein.

Purpose:

  • To investigate the effect of the SH2-Caspase 8 fusion protein on the apoptosis of K562/G01 cells.
  • To assess the potential of SC as a therapeutic agent against imatinib-resistant CML.

Summary:

  • High infection efficiency of SC on K562/G01 cells was confirmed.
  • Expression of SH2-Caspase 8-HA fusion protein was verified, leading to observable apoptosis.
  • Flow cytometry and DNA ladder assays demonstrated significant early apoptosis induction.
  • Western blot analysis revealed increased levels of apoptosis-related proteins Caspase 3 and PARP.

Impact:

  • SC effectively induces apoptosis in imatinib-resistant K562/G01 cells.
  • This study provides a potential new strategy for treating CML resistant to imatinib.
  • The findings highlight the therapeutic potential of targeted gene therapy using recombinant adenoviruses.